Multidisciplinary sickle cell disease obstetrics care program in Ghana: Non-academic vs.Academic Hospital (Pilot Study)

加纳多学科镰状细胞病产科护理计划:非学术医院与学术医院(试点研究)

基本信息

项目摘要

With increasing life expectancy in Africa, pregnancy has become an emerging life-threatening complication in SCD women. In low and middle-income countries, the odds ratio of maternal death associated with SCD is 22.81, 95% CI 14.67–35.46.1 From 2012-2014, the Obstetrics Department, Korle-Bu Teaching Hospital (KBTH), Accra, Ghana, established an obstetrician-led SCD Obstetrics (OB) clinic. The Institutional maternal mortality for SCD over these three years (2012-2014) was approximately 12%. In January 2015, a multidisciplinary SCD OB team was established. The team conducted a combined retrospective/ prospective case series of all maternal deaths in women with SCD at KBTH over seven years (2010-2016).2 This retrospective data collection highlighted failures and challenges to delivering improved care. Acute chest syndrome, preceded by acute pain episodes, was the leading cause of death in nearly 87% of women.2 In May 2015, the team implemented a joint obstetrics/ hematology clinic, instituted close maternal and fetal monitoring, and implemented clinical guidelines/ protocols. In addition, the SCD OB team established a weekly communication system to adjudicate the management of challenging cases. These interventions resulted in an 89.1% risk reduction in maternal mortality (from 10,791 to 1,176 deaths per 100,000 live births; p=0.007) over 13 months.3 Since initiating our multidisciplinary SCD OB program, we have consistently decreased maternal mortality in this cohort by approximately 90% compared to before the team was established.4,5 This physician-mentored application aims to conduct an Effectiveness-Implementation Feasibility Study to extend our results of decreasing maternal mortality from an academic hospital to a non- academic hospital setting in Accra, Ghana with a current maternal mortality rate of 5,940 deaths/ 100,000 live births in SCD women. Over five years, the applicant will acquire the skills to use the Consolidated Framework for Implementation Research (CFIR)6 and the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance)7 to inform the stages of the study. The applicant will test the hypothesis that " In a before and after study design, the applicant will test the hypothesis that multi- disciplinary care and task-shifting in a non-academic hospital for pregnant women with SCD will have an 80% relative risk reduction in death compared to the mortality rate in the same hospital before the multi-disciplinary medical care." The specific aims for this mentored award are: 1) Identify contextual determinants (barriers/ facilitators) that influence the adaptability of the evidence-based practice for establishing a multidisciplinary SCD OB team as an intervention in the non-academic hospital, including the implementation process (Years 1-2); 2) Build capacity for a multidisciplinary SCD OB program in a non- academic hospital (Years 3-5), and 3) Conduct a Hybrid type 1 feasibility study comparing the effectiveness of a task-shifted multidisciplinary SCD OB program in a non-academic site (Years 3-5).
随着非洲的预期寿命增加,怀孕已成为一种危及生命的并发症 在SCD妇女中。在低收入和中等收入国家,与SCD相关的遗产死亡率 IS 22.81,95%CI 14.67–35.46.1 2012- 2014年,Korle-Bu教学医院妇产部 (KBTH),加纳阿克拉,建立了由妇产科主导的SCD妇产科(OB)诊所。机构母亲 在这三年(2012-2014)中,SCD的死亡率约为12%。 2015年1月, 建立了多学科SCD OB团队。该团队进行了回顾/潜在的合并 SCD女性在七年(2010-2016)的SCD女性中所有物质死亡的病例系列。2 回顾性数据收集强调了失败和挑战,以提供改进的护理。急性胸部 综合征在急性疼痛发作之前是近87%的女性死亡的主要原因。2 2015年5月,该小组实施了联合妇产科/血液学诊所,建立了近母校和胎儿 监视并实施临床准则/协议。此外,SCD OB团队建立了一个 每周沟通系统调整挑战案例的管理。这些干预措施 导致孕产妇死亡率的风险降低89.1%(每100,000例活生生的死亡人数从10,791人增加到1,176人; p = 0.007)超过13个月。3自启动我们的多学科SCD OB计划以来 与团队之前,该队列中的材料死亡率降低了约90% 已建立。4,5这个物理资产的应用程序旨在进行有效性实施 可行性研究以扩展我们从学术医院降低遗产死亡率到非 - 加纳阿克拉的学术医院环境目前的死亡率为5,940人/ 100,000 SCD女性的活产。五年来,申请人将获得使用合并的技能 实施研究框架(CFIR)6和RE-AIM框架(覆盖范围,有效性, 收养,实施和维护)7以告知研究的阶段。申请人将测试 假设“在研究之前和之后,申请人将检验以下假设。 SCD孕妇的非学术医院的纪律护理和任务转移 与同一医院的死亡率相比 多学科的医疗保健。 确定影响基于证据实践的适应性的(障碍/促进者) 建立一个多学科的SCD OB团队作为对非学术医院的干预,包括 实施过程(1 - 2年); 2)在非 - 学术医院(3-5年)和3)进行比较有效性的混合型1型可行性研究 在非学术地点(3-5年)中的任务班多学科SCD OB计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eugenia Vicky Asare其他文献

A Working Definition of Acute Chest Syndrome without the Requirement of Chest X-Rays
  • DOI:
    10.1182/blood-2023-191001
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Alejandro R. Gonzalez-Barreto;Jose A. Mejias;Michael R. DeBaun;Eugenia Vicky Asare;Samuel A. Oppong
  • 通讯作者:
    Samuel A. Oppong
An e-Health Pain Assessment Tool Incorporating Animations and Images Is Feasible and Useful for Patients in a Ghanaian Sickle Cell Disease Cohort
  • DOI:
    10.1182/blood-2024-198985
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Modesty Obasohan;Catherine I. Segbefia;Charles R. Jonassaint;Eugenia Vicky Asare;Yvonne Dei Adomakoh;Cheryl Hillery;Olubusola Oluwole
  • 通讯作者:
    Olubusola Oluwole

Eugenia Vicky Asare的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
  • 批准号:
    32302894
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
非洲猪瘟病毒pS273R通过切割G3BP1调控宿主应激颗粒形成的机制
  • 批准号:
    32302893
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
抗体依赖性增强效应介导非洲猪瘟病毒致病的分子机制
  • 批准号:
    32373024
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
非洲爪蟾IV型干扰素IFN-upsilon在不同发育阶段的抗病毒功能研究
  • 批准号:
    32303043
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 8.53万
  • 项目类别:
Point of care diagnostic for sickle cell disease
镰状细胞病的护理点诊断
  • 批准号:
    10739074
  • 财政年份:
    2023
  • 资助金额:
    $ 8.53万
  • 项目类别:
Sickle Pan-African Research Consortium (SPARCO) Uganda: Strengthening Capacity for Clinical Care, Research and Training in Sickle Cell Disease - SCRT Project.
镰状细胞泛非研究联盟 (SPARCO) 乌干达:加强镰状细胞病临床护理、研究和培训的能力 - SCRT 项目。
  • 批准号:
    10414949
  • 财政年份:
    2021
  • 资助金额:
    $ 8.53万
  • 项目类别:
MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics
MEDSCAN:用于血吸虫病控制分析的移动诊断
  • 批准号:
    10279946
  • 财政年份:
    2021
  • 资助金额:
    $ 8.53万
  • 项目类别:
MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics
MEDSCAN:用于血吸虫病控制分析的移动诊断
  • 批准号:
    10654812
  • 财政年份:
    2021
  • 资助金额:
    $ 8.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了